Annual Accounts Payable
$14.17 M
+$4.85 M+51.98%
December 31, 2024
Summary
- As of March 10, 2025, DNA annual accounts payable is $14.17 million, with the most recent change of +$4.85 million (+51.98%) on December 31, 2024.
- During the last 3 years, DNA annual accounts payable has risen by +$5.98 million (+73.02%).
- DNA annual accounts payable is now at all-time high.
Performance
DNA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$14.17 M
-$1.53 M-9.75%
December 31, 2024
Summary
- As of March 10, 2025, DNA quarterly accounts payable is $14.17 million, with the most recent change of -$1.53 million (-9.75%) on December 31, 2024.
- Over the past year, DNA quarterly accounts payable has stayed the same.
- DNA quarterly accounts payable is now -59.81% below its all-time high of $35.26 million, reached on March 31, 2022.
Performance
DNA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DNA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +52.0% | 0.0% |
| 3 y3 years | +73.0% | 0.0% |
| 5 y5 years | - | 0.0% |
DNA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.0% | -59.8% | +73.0% |
| 5 y | 5-year | at high | +73.0% | -59.8% | +99.5% |
| alltime | all time | at high | +73.0% | -59.8% | +99.5% |
Ginkgo Bioworks Holdings Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $14.17 M(+52.0%) | $14.17 M(-9.8%) |
| Sep 2024 | - | $15.70 M(-31.8%) |
| Jun 2024 | - | $23.03 M(-14.7%) |
| Mar 2024 | - | $27.00 M(+189.6%) |
| Dec 2023 | $9.32 M | $9.32 M(-13.3%) |
| Sep 2023 | - | $10.75 M(-21.1%) |
| Jun 2023 | - | $13.63 M(-36.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $21.57 M(+106.4%) |
| Dec 2022 | $10.45 M(+27.6%) | $10.45 M(-7.7%) |
| Sep 2022 | - | $11.32 M(-41.8%) |
| Jun 2022 | - | $19.46 M(-44.8%) |
| Mar 2022 | - | $35.26 M(+330.5%) |
| Dec 2021 | $8.19 M(-41.1%) | $8.19 M(+15.3%) |
| Sep 2021 | - | $7.10 M(-48.9%) |
| Dec 2020 | $13.89 M | $13.89 M |
FAQ
- What is Ginkgo Bioworks Holdings annual accounts payable?
- What is the all time high annual accounts payable for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual accounts payable year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly accounts payable year-on-year change?
What is Ginkgo Bioworks Holdings annual accounts payable?
The current annual accounts payable of DNA is $14.17 M
What is the all time high annual accounts payable for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual accounts payable is $14.17 M
What is Ginkgo Bioworks Holdings annual accounts payable year-on-year change?
Over the past year, DNA annual accounts payable has changed by +$4.85 M (+51.98%)
What is Ginkgo Bioworks Holdings quarterly accounts payable?
The current quarterly accounts payable of DNA is $14.17 M
What is the all time high quarterly accounts payable for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly accounts payable is $35.26 M
What is Ginkgo Bioworks Holdings quarterly accounts payable year-on-year change?
Over the past year, DNA quarterly accounts payable has changed by $0.00 (0.00%)